New recommendation of doses in an ongoing phase II study of docetaxel, oxaliplatin and capecitabine as first line therapy in advanced gastro-oesophageal cancer

Katrine R Schønnemann, Mette Yilmaz, Maria Andersen, Per Pfeiffer

Research output: Contribution to journalJournal article

Original languageEnglish
JournalActa Oncologica
Volume50
Issue number1
Pages (from-to)151-2
Number of pages2
ISSN0284-186X
DOIs
Publication statusPublished - 2011

Cite this